Thanks @Rothbard.
I think this is looking like a very nice story over the next 3-5 years if things play out properly. With the tailwinds of infrastructure spend worldwide and a lean operation, with its very low market capitalisation, we could easily get 10-20x returns in that timeframe (will be lots of ups and downs and sideways though).
Still maintain my 45c target for next FY, they tend to be pretty conservative with guidance.
I am personally not a fan of the DRP idea, just concentrate on the business and the returns will look after themselves...
Correct me if I'm wrong, the Dividend Reinvestment provides a tax incentive for shareholders. It could also provide funds for the company for future growth. I'm not sure exactly how it all works.
They have also mentioned, with gearing at only 16%, they might use some debt to fund growth.
What's your reason for not being a fan of it, if you don't mind me asking?
- Forums
- ASX - By Stock
- SRH
- Ann: Results of Meeting
SRH
saferoads holdings limited
Add to My Watchlist
0.00%
!
8.5¢

Ann: Results of Meeting, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.714M |
Open | High | Low | Value | Volume |
8.5¢ | 8.5¢ | 8.5¢ | $595 | 6.999K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50001 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50001 | 0.084 |
1 | 10000 | 0.080 |
2 | 170000 | 0.072 |
2 | 40000 | 0.050 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 30000 | 1 |
0.100 | 52254 | 1 |
0.150 | 12600 | 1 |
0.175 | 63254 | 2 |
0.000 | 0 | 0 |
Last trade - 12.11pm 04/07/2025 (20 minute delay) ? |
Featured News
SRH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online